Current status of bacteriophage therapy for severe bacterial infections

T Sawa, K Moriyama, M Kinoshita - Journal of Intensive Care, 2024 - Springer
The increase in the incidence of antibiotic-resistant bacteria poses a global public health
threat. According to a 2019 WHO report, approximately 1.27 million deaths were attributed to …

Translational research priorities for bacteriophage therapeutics

RT Schooley - Essays in Biochemistry, 2024 - portlandpress.com
The growing threat of antimicrobial resistant (AMR) bacterial pathogens coupled with the
relative dearth of promising novel antibiotics requires the discovery and development …

Phage Therapy for Cardiac Implantable Electronic Devices and Vascular Grafts: A Targeted Literature Review

M Passerini, F Petri, GA Suh - Pathogens, 2024 - mdpi.com
Infections of cardiac implantable electronic devices (CIEDs) and vascular grafts are some of
the most dreaded complications of these otherwise life-saving devices. Many of these …

[HTML][HTML] Bacteriophages: A Challenge for Antimicrobial Therapy

N Segundo-Arizmendi, D Arellano-Maciel… - Microorganisms, 2025 - mdpi.com
Phage therapy, which involves the use of bacteriophages (phages) to combat bacterial
infections, is emerging as a promising approach to address the escalating threat posed by …

From crisis to cure: harnessing the potential of mycobacteriophages in the battle against tuberculosis

NM Bin Yahia, M Shan, Y Zhu, Y Yang… - Journal of Applied …, 2024 - academic.oup.com
Tuberculosis (TB) is a serious and fatal disease caused by Mycobacterium tuberculosis
(Mtb). The World Health Organization reported an estimated 1.30 million TB-related deaths …

Ventricular Assist Device Infections: Epidemiology, Treatment, and Outcomes in Transplant

GB DeMarco, RN Kumar - Current Treatment Options in Infectious …, 2024 - Springer
Abstract Purpose of Review To review the current literature on ventricular assist device
(VAD) infections, with emphasis on epidemiology, treatment, and post-transplant outcomes …